EU: EUDAMED UDI/device registration and Certificates and Notified Bodies modules available by September 2021.
The European Commission announced the activation of the modules on UDI/device registration (second module) and on Certificates and Notified Bodies (third module) by September 2021. The first module on Actor registration is available since December 2020.
EUDAMED will act as central repository of information to lay the foundation for collaboration, transparency and interaction of all parties, namely the new European databank for medical devices and in vitro diagnostic devices.
EUDAMED will have several modules and contain extensive data. The data will allow access to all stakeholders including the European Commission, NCAs, Notified Bodies, MAID, Sponsors and the public.
Do you know how to register for EUDAMED? Contact Meditrial to learn everything you need to know on how to prepare! With us, you will be the first to comply.
Read Meditrial’s whitepaper to learn more on the MDR and Eudamed.
Sign up to Mastertrial course offerings to find free training and opportunities for professional certification.
Contact Meditrial for immediate assistance in Europe or the US.
Table of Contents
Getting a CE mark for medical devices: a step-by-step guide
Practical guidance on the CE mark for medical devices under EU MDR, from classification and evidence to conformity assessment and EUDAMED
A Practical RBQM Framework for Medical Device Trials
Risk-based quality management for medical device trials, with practical actions for risk assessment, monitoring, data review, and trial oversight
EU Breakthrough Medical Devices Under MDCG 2025-9 (BtX)
EU breakthrough medical devices gain a clearer regulatory pathway under MDCG 2025-9, with early advice and lifecycle evidence planning
What Swissmedic Fast-Track Means for Clinical Trial Sponsors
Swissmedic swissethics Fast-Track Pilot Project accelerates eligible trial reviews and makes coordinated regulatory preparation increasingly important.
FDA Breakthrough Device Acceleration
How innovative MedTech companies can accelerate FDA approval, secure Medicare coverage, and reach patients faster—starting with Breakthrough Device Designation.
The contribution of patient associations in clinical trials
Historically, patient organizations have had the primary purpose of supporting the communities they represented. Today, this remains a crucial function, but modes have changed, as has the role that associations and patients themselves take on [...]
This article provides general information and does not constitute regulatory or legal advice. Requirements should be confirmed for the specific study, applicable regulatory framework, and markets concerned.
